Demo Day

Day 3 14/10/2026

Event Details

HKU Demo Day x Innovation Week 2026 — The premier platform for entrepreneurial talent ready to take the spotlight!

HKU Demo Day is designed for all HKU-affiliated startups and members of the HKU Innovation and Entrepreneurship (I&E) ecosystem. At each event, promising startups showcase their business plans and latest progress to a curated audience of industry experts and venture capital investors. Each team will have a 5-minute pitch to present their ideas. A panel of distinguished judges will select the winning teams, who will have the opportunity to receive complimentary co-working space support from iDendron, as well as the chance to showcase their projects through an exhibition to further accelerate their growth.

Name	Description	Representative / PI
AstRAN	AstRAN is an AI-powered semantic satellite communications company dedicated to empowering a wide range of industries through satellite connectivity. To address the high cost and power consumption of broadband satellite terminals, as well as the limited ability of narrowband satellite terminals to transmit images, video, and other multimodal content, AstRAN has developed a generative semantic communications architecture that coordinates devices, satellites, and the cloud.	Dr. Zongyao ZHAO Prof. Yuanwei LIU (Academic PIC)
BiomOrgan Limited	BiomOrgan is developing a human respiratory organoid-based platform for the discovery and preclinical evaluation of antiviral drugs, vaccines, and therapeutic antibodies. The platform supports the isolation and propagation of difficult-to-culture respiratory viruses, antiviral drug screening, and evaluation of vaccines and neutralizing antibodies in a more human-relevant respiratory environment.	Dr. Yong ZHANG Prof. Jie ZHOU (Academic PIC)
BlueStar ADC HK	BlueStar ADC is a chemistry-innovation driven biotech startup focusing on next-generation ADC discovery. The company's pipelines concentrate on disease areas with massive unmet medical need such as gastrointestinal cancers and autoimmune/inflammatory indications. The founding team of BlueStar ADC comprises of seasoned veterans of drug discovery in top-tier pharmas and experts in the field. The company holds core patents on innovative linker-payload platform, aiming to overcome resistance and toxicity hurdles faced by classical ADCs. We thrive to develop First-in-class and Best-in-class precision targeted therapy globally.	Dr. Zijun WANG
Dayu Technologies	InfiniFetch is a city-scale world model platform built for the future of network technology. We unify the physical space, connection relationships, and social behavior of a real city into a single world model that can be simulated, reasoned over, and optimized. The common thread running through everything we do is connection.	Prof. Hongyang DU (Academic PIC)
DiffuSpace	DiffuSpace is building diffusion language models as a foundation for the next generation of intelligence. Through parallel generation, bidirectional modeling, and iterative refinement, we aim to move beyond the constraints of autoregressive generation toward intelligence that is more flexible, efficient, and controllable.	Dr. Han ZHANG Prof. Lingpeng KONG (Academic PIC)
Efficore Semiconductor	Efficore Semiconductor is dedicated to resolving the critical power delivery bottlenecks of the global AI revolution, where low-voltage power conversion has become the ultimate efficiency barrier for high-density data centers. To overcome this, we pioneer next-generation 15V Gallium Nitride (GaN) power semiconductor technologies specifically tailored for advanced 800V data center architectures.	Mr. Xin YANG Prof. Yuhao ZHANG (Academic PIC)
FluviusH2	Jianghe Hydrogen develops enzyme-coupled electrolysis tech that slashes green H₂ cost by 2/3 and energy use by 50%. Using engineered biocatalysts from Oxford, HKU & Max Planck, it enables direct seawater splitting, replaces platinum, and cuts OpEx. Near-term FH1 retrofits existing ALK electrolyzers; FH2/FH3 target modular, low-power on-site generation. Backed by HK-based platform with patents and pilot orders.	Dr Zehui DUAN Dr Xuan GAO (Academic PIC)
IINCA LIMITED	IINCA helps businesses and other non-domestic water users detect leakage and diagnose abnormal water-use from existing water meter data. Our non-invasive IoT technology and AI-powered analytics support utilities, commercial buildings, and housing estates with high-resolution monitoring, automated anomaly detection, and diagnosis-focused insights. The system works with existing metering infrastructure, reducing the need for meter replacement or disruptive installation, while helping users improve water efficiency and strengthen sustainability and ESG performance.	Dr. Angela LEE
Metasurgical Technology Limited	Metasurgical Technology Limited focuses on addressing one core challenge: enabling robots to deliver services for vulnerable populations. To this end, we independently developed ‘mskalign’, an efficient closed-loop clinical data framework and full-stack clinical service toolchain that serves as the core engine powering continuous AI advancement. This engine integrates specialized medical comprehension, spatial intelligence, physical reasoning, and autonomous decision-making, equipping robots with generalized service and interaction capabilities across outpatient clinics, hospital wards, and rehabilitation care facilities.	Dr. Xihe KUANG Prof. Teng Grace ZHANG (Academic PIC)
NeuroHarbor Limited	NeuroHarbor is dedicated to building an AI-powered brain health diagnosis and treatment platform, with the mission of "managing brain disorders like chronic diseases," addressing industry challenges such as time-consuming EEG interpretation, shortage of medical professionals, and lack of continuous monitoring for patients. The core product is an AI-based EEG analysis software, trained on intracranial and scalp EEG data from over 3,360 hours across four countries; the software achieves a sensitivity of 95.59%, specificity of 96.93%, and accuracy of 96.90% in detecting interictal epileptiform discharges (IEDs) on internal test sets, enabling detection within approximately one second.	Ms. Yazhou ZHAO
NORDIA BIOTECH & PHARMACEUTICALS HK LTD	Nordia targets on the diabetes with personal or universal islet organoids generated from stem cells through its original unique patented self-developed method enabling spontaneous formation of 3D structure of islets.	Dr. Fei LONG Prof. Zhongjun ZHOU (Academic PIC)
Shenzhen Stellar Robot Technology Co., Limited	The company specialises in full‑stack in‑house R&D of “algorithms + hardware” for dexterous hands, with 100% domestically developed and proprietary technology. It has built a complete closed‑loop system spanning micro joint modules, dexterous hands, embodied data acquisition, and the VTLAM embodied manipulation model.	Mr Dehao WEI

Name

Description

Representative / PI

AstRAN

AstRAN is an AI-powered semantic satellite communications company dedicated to empowering a wide range of industries through satellite connectivity. To address the high cost and power consumption of broadband satellite terminals, as well as the limited ability of narrowband satellite terminals to transmit images, video, and other multimodal content, AstRAN has developed a generative semantic communications architecture that coordinates devices, satellites, and the cloud.

Dr. Zongyao ZHAO Prof. Yuanwei LIU (Academic PIC)

BiomOrgan Limited

BiomOrgan is developing a human respiratory organoid-based platform for the discovery and preclinical evaluation of antiviral drugs, vaccines, and therapeutic antibodies. The platform supports the isolation and propagation of difficult-to-culture respiratory viruses, antiviral drug screening, and evaluation of vaccines and neutralizing antibodies in a more human-relevant respiratory environment.

Dr. Yong ZHANG Prof. Jie ZHOU (Academic PIC)

BlueStar ADC HK

BlueStar ADC is a chemistry-innovation driven biotech startup focusing on next-generation ADC discovery. The company's pipelines concentrate on disease areas with massive unmet medical need such as gastrointestinal cancers and autoimmune/inflammatory indications. The founding team of BlueStar ADC comprises of seasoned veterans of drug discovery in top-tier pharmas and experts in the field. The company holds core patents on innovative linker-payload platform, aiming to overcome resistance and toxicity hurdles faced by classical ADCs. We thrive to develop First-in-class and Best-in-class precision targeted therapy globally.

Dr. Zijun WANG

Dayu Technologies

InfiniFetch is a city-scale world model platform built for the future of network technology. We unify the physical space, connection relationships, and social behavior of a real city into a single world model that can be simulated, reasoned over, and optimized. The common thread running through everything we do is connection.

Prof. Hongyang DU (Academic PIC)

DiffuSpace

DiffuSpace is building diffusion language models as a foundation for the next generation of intelligence. Through parallel generation, bidirectional modeling, and iterative refinement, we aim to move beyond the constraints of autoregressive generation toward intelligence that is more flexible, efficient, and controllable.

Dr. Han ZHANG Prof. Lingpeng KONG (Academic PIC)

Efficore Semiconductor

Efficore Semiconductor is dedicated to resolving the critical power delivery bottlenecks of the global AI revolution, where low-voltage power conversion has become the ultimate efficiency barrier for high-density data centers. To overcome this, we pioneer next-generation 15V Gallium Nitride (GaN) power semiconductor technologies specifically tailored for advanced 800V data center architectures.

Mr. Xin YANG Prof. Yuhao ZHANG (Academic PIC)

FluviusH2

Jianghe Hydrogen develops enzyme-coupled electrolysis tech that slashes green H₂ cost by 2/3 and energy use by 50%. Using engineered biocatalysts from Oxford, HKU & Max Planck, it enables direct seawater splitting, replaces platinum, and cuts OpEx. Near-term FH1 retrofits existing ALK electrolyzers; FH2/FH3 target modular, low-power on-site generation. Backed by HK-based platform with patents and pilot orders.

Dr Zehui DUAN Dr Xuan GAO (Academic PIC)

IINCA LIMITED

IINCA helps businesses and other non-domestic water users detect leakage and diagnose abnormal water-use from existing water meter data. Our non-invasive IoT technology and AI-powered analytics support utilities, commercial buildings, and housing estates with high-resolution monitoring, automated anomaly detection, and diagnosis-focused insights. The system works with existing metering infrastructure, reducing the need for meter replacement or disruptive installation, while helping users improve water efficiency and strengthen sustainability and ESG performance.

Dr. Angela LEE

Metasurgical Technology Limited

Metasurgical Technology Limited focuses on addressing one core challenge: enabling robots to deliver services for vulnerable populations. To this end, we independently developed ‘mskalign’, an efficient closed-loop clinical data framework and full-stack clinical service toolchain that serves as the core engine powering continuous AI advancement. This engine integrates specialized medical comprehension, spatial intelligence, physical reasoning, and autonomous decision-making, equipping robots with generalized service and interaction capabilities across outpatient clinics, hospital wards, and rehabilitation care facilities.

Dr. Xihe KUANG Prof. Teng Grace ZHANG (Academic PIC)

NeuroHarbor Limited

NeuroHarbor is dedicated to building an AI-powered brain health diagnosis and treatment platform, with the mission of "managing brain disorders like chronic diseases," addressing industry challenges such as time-consuming EEG interpretation, shortage of medical professionals, and lack of continuous monitoring for patients. The core product is an AI-based EEG analysis software, trained on intracranial and scalp EEG data from over 3,360 hours across four countries; the software achieves a sensitivity of 95.59%, specificity of 96.93%, and accuracy of 96.90% in detecting interictal epileptiform discharges (IEDs) on internal test sets, enabling detection within approximately one second.

Ms. Yazhou ZHAO

NORDIA BIOTECH & PHARMACEUTICALS HK LTD

Nordia targets on the diabetes with personal or universal islet organoids generated from stem cells through its original unique patented self-developed method enabling spontaneous formation of 3D structure of islets.

Dr. Fei LONG Prof. Zhongjun ZHOU (Academic PIC)

Shenzhen Stellar Robot Technology Co., Limited

The company specialises in full‑stack in‑house R&D of “algorithms + hardware” for dexterous hands, with 100% domestically developed and proprietary technology. It has built a complete closed‑loop system spanning micro joint modules, dexterous hands, embodied data acquisition, and the VTLAM embodied manipulation model.

Mr Dehao WEI

HKU INNOVATION WEEK 2026

Demo Day

Event Details

Event Information

Recent Programmes

YPO 4.0 Shenzhen Visit to Qianhai & HKU TEA

Global Entreprenuership Challenge

Social Venture Champions – Pitching Day